The Business Research Company’s Glioblastoma Multiforme (GBM) Treatment Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Glioblastoma Multiforme (GBM) Treatment Global Market Report 2023 evaluates glioblastoma multiforme (GBM) treatment market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8803&type=smp
The global glioblastoma multiforme (GBM) treatment market is expected to grow from $2.04 billion in 2022 to $2.26 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The glioblastoma multiforme (GBM) treatment market is expected to grow to $3.26 billion in 2027 at a CAGR of 9.7%.
The glioblastoma multiforme (GBM) treatment market segments in the report are:
By Treatment:
Surgery
Radiation Therapy
Chemotherapy
Targeted Therapy
Tumor Treating Field (TTF) Therapy
Immunotherapy
By Drug Class:
Temozolomide
Bevacizumab
Lomustine
Carmustine Wafers
Other Drug Classes
By Route of Administration:
Oral
Parenteral
Other Route Of Administrations
By End-Use:
Hospitals
Clinics
Ambulatory Surgical Centers
Top Major Players:
North America was the largest region in the glioblastoma multiforme (GBM) treatment market in 2022.
Get More Information On The Glioblastoma Multiforme (GBM) Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/glioblastoma-multiforme-GBM-treatment-global-market-report
The table of contents in TBRC’s glioblastoma multiforme (GBM) treatment market report includes:
1. Executive Summary
2. Glioblastoma Multiforme (GBM) Treatment Market Characteristics
3. Glioblastoma Multiforme (GBM) Treatment Market Trends And Strategies
4. Glioblastoma Multiforme (GBM) Treatment Market – Macro Economic Scenario
5. Glioblastoma Multiforme (GBM) Treatment Market Size And Growth
………
26. Africa Glioblastoma Multiforme (GBM) Treatment Market
27. Glioblastoma Multiforme (GBM) Treatment Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Glioblastoma Multiforme (GBM) Treatment Market
29. Glioblastoma Multiforme (GBM) Treatment Market Future Outlook and Potential Analysis
30. Appendix
List Of Tables
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
……
Table 47: Merck & Co Inc. Financial Performance
Table 48: F. Hoffmann-La Roche AG Financial Performance
Table 49: Amgen Inc. Financial Performance
Table 50: Pfizer Inc. Financial Performance
Table 51: Teva Pharmaceutical Industries Ltd. Financial Performance
Read Related Reports:
Neurology Devices Global Market Report 2023
Neurodegenerative Disorder Therapeutics Global Market Report 2023
Neurophysiology Devices And Equipment Global Market Report 2023
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
